EBITDA: Income before interest, taxes, depreciation and amortization.
180 Life Sciences Corp. (ATNF) had EBITDA of $-1.73M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.73M |
|
-- |
|
-- |
|
$1.73M |
|
$-1.73M |
|
$0.00M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
|
EBITDA |
$-1.73M |
5.71M |
|
5.71M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$3.09M |
|
-- |
|
$7.62M |
|
$10.71M |
|
$5.33M |
|
-- |
|
-- |
|
$5.33M |
|
$5.38M |
|
$-2.24M |
|
$5.38M |
|
6.04M |
|
| Cash Flow Statement Financials | |
$-1.98M |
|
-- |
|
$-0.35M |
|
$4.59M |
|
$2.22M |
|
$-2.37M |
|
$0.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.09% |
|
77.03% |
|
-16.12% |
|
-32.09% |
|
$0.89 |
|
$-0.35 |
|
$-0.35 |
|